John Richert, Paul Wood, Ken Tindall, Nicholas Roelofs, Joseph Sorge, Janet Lankard, Paul Lucas, Neil Reid, Michael Mueller, Stevan Jovanovich, Scott Lockard, Arden Bement Jr., Rita Colwell, Michael Yeomans | GenomeWeb

John Richert has been named vice president of the business and technology development program at the North Carolina Biotechnology Center in Research Triangle Park. Richert, previously vice president of business development at Aeolus Pharmaceuticals, succeeds Paul Wood, who retired in August 2003. He will report to Ken Tindall, senior vice president for science and business development. Richert will oversee and manage the center’s loan programs, venture capital investments, and technology-transfer and business-development activities.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.